NEWS
SUBSCRIBER SEARCH (Requires Login)
  NEW DRUGS
  MARKETED DRUGS
  COMPANY
  TARGETS IN ONCOLOGY
  NEWS SUMMARIES
  COMBINATION TRIALS

Latest Updates

First Quarter 2010 Marketed Drug Updates and Additions

Brand Name

Generic Name

Other Designation

 

 

WF10

Abraxane

Nanoparticle albumin-bound (nab) paclitaxel, paclitaxel albumin bound (PAB)

ABI-007

Afinitor (cancer), Certican (immunosuppression)

Everolimus

RAD001, RAD001C

Alimta

Pemetrexed disodium

LY 231514

Amnolake, Amnoid, Amnoleuk, Tamibaro

Tamibarotene

Am80, Am-80, TOS-80T

Arzerra

Ofatumumab

HuMax-CD20, GSK1841157

Avastin

Bevacizumab

rhuMAb-VEGF, NSC-704865, R435, RG435

Celebrex (formerly known as Celebra)

Celecoxib

SC-236, SC-58635

Ceplene (formerly Maxamine and EpiLeukin)

Histamine dihydrochloride

 

Cytostasan, Ribomustin (Europe), Treanda (USA), Levact (Europe)

Bendamustin, bendamustin HCl, bendamustine

ZIMET 3393, SDX-105 (USA), SyB L-0501 (Asia)

D-TRP-6-LHRH, Debio 8206

Catumaxomab

 

Evista • Optruma (Europe, formerly Celvista)

Raloxifene

 

Gardasil, Silgard (Eastern Europe)

Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine

 

Gemzar

Gemcitabine

 

Gleevec (USA, Canada, Israel), Glivec (Europe)

Imatinib mesylate

STI-571, STI571, formerly CGP-57148B

Glutoxim (Russia)

 

BAM-002, NOV-002 (USA)

Herceptin

Trastuzumab

RG597, formerly rhuMAb HER2

Hycamtin, Hycaptamine

Topotecan

NSC-609699, SK&F-104864

Ixempra

Ixabepilone

BMS-247550, BMS247550, NSC 710428, NSC 710428D

Levulan Kerastick PDT

5-aminolevulinic acid (5-ALA)

 

Nikidess, Aromasin

Exemestane

FCE 24304

OncoVAX

 

 

Proleukin

Aldesleukin (IL-2)

NSC-373364

Rituxan (USA), MabThera (Europe)

Rituximab

IDEC-C2B8, RG105

Sprycel

Dasatinib

BMS-354825

Sutent

Sunitinib malate

SU011248, SU11248, SU-11248

Tarceva

Erlotinib

CP 358774, OSI-774, R1415, RG1415, NSC 718781

Tasigna

Nilotinib

AMN107, AMN-107

Trellasar, De-Capeptyl (UK), Trelstar LA (USA), Trelstar Depot (USA), Decapeptyl (Europe), Pamorelin (Germany)

Triptorelin pamoate

D-TRP-6-LHRH, Debio 8206

Tykerb (USA, EU), Tyverb

Lapatinib ditosylate

572016, GW572016, GW 572016, GSK 572016

Vectibix

Panitumumab

ABX-EGF (formerly known as clone E7.6.3)

Xeloda

Capecitabine

Ro 09-1978, RG340

Zometa

Zoledronate, zoledronic acid

ZOL 446/ CGP 42446

Zyclara

Imiquimod

 

  

Home   |    Freelance Opportunities   |   New Medicine   |   Site Map   |  Order/Inquiry   
SUBSCRIBER SEARCH:   NEW DRUG   |   MARKETED DRUG   |   COMPANY   |   TARGETS IN ONCOLOGY  

NEW MEDICINE, INC.
P.O. BOX 909, LAKE FOREST, CA 92609
PHONE:  1-949-830-0448     FAX:  1-949-830-0887
INFO@NEWMEDINC.COM